The expression osimertinib xenograft has emerged as a major advancement in the domain of cancer research.Non-small cell lung cancer (NSCLC)-targeted therapy osimertinib has shown significant effectiveness in medical trials.When the concept of xenograft, involving the transplantation of tumor cells from one one organism to another, is merged with it, this area of study opens up new avenues for knowledge and management of cancer.Osimertinib is a strong inhibitor of the EGFR (epidermal growth factor receptor) tyrosine kinase, commonly mutated in NSCLC patients.Through targeting this specific pathway, osimertinib has demonstrated its ability…
